Similar phenomenon occurs in bladder cancer, so that curcumin administration (0–50 μM) decreases CD44, CD133, ALDH1, Nanog and Oct4 to impair CSC characteristics in bladder cancer and induce apoptosis and proliferation inhibition. This evidence concerns the gene POU5F1 and urinary bladder cancer.